Iodine I-124 Evuzamitide

DB18394InvestigationalProtein Based Therapies

Iodine I-124 Evuzamitide: Overview.

Mechanism
Curator reviewed
Also known as
124I-p5+14 · Evuzamitide Iodine I-124 · Glycylglycylglycyl-3-(iodo-124I)-L-tyrosyl-L-seryl-L-lysyl-L-alanyl-L-glutaminyl-L-lysyl-L-alanyl-L-glutaminyl-L-alanyl-L-lysyl-L-glutaminyl-L-alanyl-L-lysyl-L-glutaminyl-L-alanyl-L-glutaminyl-L-lysyl-L-alanyl-L-glutaminyl-L-lysyl-L-alanyl-L-glutaminyl-L · Iodine (124i) evuzamitide · iodine (¹²⁴I) evuzamitide
Code names
APi1832 · AT-01 · IAT-01

Resolves to

What you can answer from here — as of July 09, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Iodine I-124 Evuzamitide, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account